Central regions | Technology & innovation

Russian vaccine against omicron COVID strain to be tested

1 Dec '21
The Human Stem Cell Institute will conduct experiments to evaluate the effectiveness of the Betuvax-cov-2 vaccine against the omicron strain. It was developed by the resident of the Skolkovo Foundation (VEB.RF Group), Betuvax, a member of the HSCI group.

The assessment will take up to four weeks. If necessary, the Human Stem Cell Institute will consider modifying the vaccine. The company noted that the Betuvax-cov-2 vaccine is effective in neutralizing the most common serotypes of the virus.
Artur Isaev, Chairman of the Board of Directors of HSCI: We will consider the modification, but so far our data show that the vaccine has quite good properties in neutralizing the most common serotypes of the virus. If we see that there is a spread of some new strains, in relation to which the neutralizing properties of the vaccine are reduced, then we will make a vaccine against this particular strain.

Ivan Taskin, project manager of the Skolkovo Foundation's Biomedical Technologies Cluster: The variability of the SARS CoV-2 virus forces scientists to improve vaccines, and this trend can be traced everywhere. In case of successful clinical trials, the Betuvax-Cov-2 vaccine developed by Betuvax-Cov-2 can become another platform for the successful prevention of the spread of coronavirus.
The Betuvax-Cov-2 Vaccine - subunit recombinant vaccine based on spherical particles with a surface antigen (protein) of the coronavirus. Subunit vaccines are less likely to cause side effects, which is especially important for risk groups and have good prospects when used for repeated - booster vaccinations. The design of the Betuvax-CoV-2 vaccine also makes it possible to quickly optimize it for new strains of coronavirus.

Clinical trials of the vaccine began in October. Production of Betuwax-Cov-2 may begin in the first half of 2022.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Tags: omicron (0) /

Latest News: Central regions
21 Jan '22 | Technology & innovation
21 Jan '22 | Technology & innovation
19 Jan '22 | Technology & innovation
 

Feature stories

27 Dec '21
An innovative hybrid plate for cranial defects...
24 Nov '21
Cerebral vascular disorders are responsible for a...
8 Oct '21
Chemists at the St. Petersburg State University...
Search (News archive - 22912)
Technology Scouting Solutions For Industry
NATT
Advertising
Marchmont News

Latest News

20 Jan '22
A research team at the Samara Polytechnic University...
18 Jan '22
A scientific team in the West Urals has come up with...
14 Jan '22
A new device, developed by a Russian start-up and...

Most read stories from last week

21 Jan '22
21 Jan '22
Russian scientists have created a robot to disinfect...